Boston Trust Walden’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
28,105
+18,753
+201% +$839K 0.01% 282
2026
Q1
$378K Buy
9,352
+1,531
+20% +$67.9K ﹤0.01% 353
2025
Q4
$359K Hold
7,821
﹤0.01% 349
2025
Q3
$358K Hold
7,821
﹤0.01% 355
2025
Q2
$322K Hold
7,821
﹤0.01% 347
2025
Q1
$273K Hold
7,821
﹤0.01% 353
2024
Q4
$300K Buy
7,821
+228
+3% +$8.59K ﹤0.01% 347
2024
Q3
$269K Buy
+7,593
New +$240K ﹤0.01% 352
2022
Q4
Sell
-11,062
Closed -$244K 364
2022
Q3
$244K Sell
11,062
-5,532
-33% -$143K ﹤0.01% 338
2022
Q2
$398K Hold
16,594
﹤0.01% 318
2022
Q1
$506K Buy
+16,594
New +$496K ﹤0.01% 316
2020
Q1
Sell
-11,295
Closed -$233K 352
2019
Q4
$233K Hold
11,295
﹤0.01% 368
2019
Q3
$214K Buy
+11,295
New +$205K ﹤0.01% 371

Other funds holding BN

Boston Trust Walden's BN Position: Q2 2026 in Review

Boston Trust Walden increased its Brookfield (BN) stake by 201% in Q2 2026, buying an estimated $839K and bringing the position to 28,105 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #282.

Boston Trust Walden first reported a position in BN in Q3 2019 and has held it in 13 quarters since. 332 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Boston Trust Walden held 28,105 shares of Brookfield worth $1.2M as of Q2 2026.
  • Boston Trust Walden bought 18,753 Brookfield shares in Q2 2026, an estimated $839K.
  • Brookfield made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #282 holding.
  • Boston Trust Walden first reported a position in Brookfield in Q3 2019 and has held it in 13 quarters since.
  • 332 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.